Business
Innovest Global Biotech Partners with Preeminent Los Angeles Association
Innovest Global Biotech Partners with Preeminent Los Angeles Association.
About this update from Innovest Global Inc
[{"type":"text","content":"\nCLEVELAND, Ohio, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST) (the “Company” or “Innovest”), a conglomerate with operations in commercial and industrial products and services, biotechnology, and construction & building materials, has secured a strategic partnership with the Southern California Biomedical Counsel. This action follows the annoucement of our Biotech Division’s world-class advisory board, and is a catalyst for the division’s 2019 business plan.\n Southern California Biomedical Counsel (SoCal Bio) is a non-profit that supports the growth of biotech, medtech, and digital health commercialization activities in the flourishing Los Angeles region. They are the leading Los Angeles biotech trade association with influence in the scientific, finacial, corporate, and government sectors. “The announcement of our team last week, and now this alignemnt with SoCal Bio signifies the end of our planning and the beginning of our execution. SoCal Bio is an ideal platform that is active with prime opportunities on the west coast that fit our requirements,” said Dr. Dwain Morris-Irvin, Innovest Biotech Division President. “This is a major development from Dr. Irvin, which appropriately puts our biotech division in a league of its own,” said Dan Martin, Innovest’s Chief Executive Officer. “Dr. Irvin precisely meets the needs of a niche with a first class team, and is poised to surpass the goal we initially defined. In addition to SoCal Bio being a preeminent organization, Ahmed Enany (SoCal Chief Executive Officer) is one of the kindest and most down to earth people I’ve ever had the pleasure to meet. Once again, I am so thankful for having the opportunity to align with such good people.” Innovest’s biotechnology division expects a variety of developments, from both StemVax and its new efforts. Innovest is enthusiastically closing out a year which was marked by a series of developments and revenue acquistions, which effectivelty set a platform that can scale significantly in 2019 and beyond. About Innovest Global, Inc. Innovest Global, Inc. (OTC Markets: IVST) is a conglomerate with operations in three divisions, which include commercial and industrial products and services, energy, biotechnology, health science...